GRIFFIN ASSET MANAGEMENT, INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 883803
New York, NY
Position in VRTX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,757,384
-$51,181 QoQ
Shares Held
6,175
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GRIFFIN ASSET MANAGEMENT, INC. holds $6,807,021 across 6 Biotechnology names. VRTX ranks #2 (40.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
191,872 | $3,637,893 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,175 | $2,757,384 | |
| 3 | ABSI |
Absci Corp
|
56,760 | $170,280 | |
| 4 | REPL |
Replimune Group, Inc.
|
14,400 | $110,160 | |
| 5 | BMEA |
Biomea Fusion, Inc.
|
58,300 | $89,199 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
14,620 | $42,105 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,757,384 | 6,175 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,808,565 | 6,195 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,436,000 | 6,220 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,852,841 | 6,408 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,886,801 | 8,017 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,274,756 | 8,132 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $4,052,242 | 8,713 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,076,926 | 8,698 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $3,679,742 | 8,803 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,645,734 | 8,960 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $3,069,848 | 8,828 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $3,092,585 | 8,788 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,768,835 | 8,788 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,657,931 | 9,204 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,770,029 | 9,567 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,711,383 | 9,622 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,513,141 | 9,630 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,686,308 | 7,679 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,246,874 | 6,874 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,386,004 | 6,874 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,159,116 | 5,394 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $884,856 | 3,744 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $983,713 | 3,615 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,097,371 | 3,780 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $906,589 | 3,810 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||